NXS 5.77% 24.5¢ next science limited

Ann: Update on expected revenue for H1, page-44

  1. 142 Posts.
    lightbulb Created with Sketch. 33
    Sales growth is slower than what we were all expecting, based on guidance but if they achieve at least USD1.5mio in the second quarter that'll be USD$5.9mio over 9 months (hopefully they'll get the result over USD6mio). Not as much as we were all hoping for but possibly the best rolling 9 month revenue they've had since listing. I understand everyone's disappointment, and I expect revenue growth to be slow over the next two quarters (new products will take time to gain traction/acceptance) but I just can't believe that when you have a great product that's reasonably priced and a sales team of significant size earning a 25% commission that you won't gain some momentum over time. DYOR IMO
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.015(5.77%)
Mkt cap ! $71.46M
Open High Low Value Volume
25.0¢ 26.0¢ 24.5¢ $30.25K 119.2K

Buyers (Bids)

No. Vol. Price($)
2 75861 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 43775 2
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.